CD326 (EpCAM) Antibody, anti-human, Vio® Bright B515, REAfinity™ 130-111-007 from Miltenyi Biotec

Product Specs
ItemCD326 (EpCAM) Antibody, anti-human, Vio® Bright B515, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-111-007
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagVio Bright B515
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
IsotypeIgG1
CloneREA764
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Nameepithelial cell adhesion molecule
NCBI Gene AliasesDIAR5, EGP-2, EGP314, EGP40, ESA, HNPCC8, KS1/4, KSA, M4S1, MIC18, MK-1, TACSTD1, TROP1
Clonalitymonoclonal
Reactivityhuman
Concentration1:50
ModificationsRecombinantly engineered
TargetCD326 (EpCAM)
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAMCancersOctober 2, 2021Belthier G, Homayed Z, Grillet F, Duperray C, Vendrell J, Krol I, Bravo S, Boyer JC, Villeronce O, Vitre-Boubaker J, et al.APC-conjugated CD44v6 antibodies (130-111-425, Miltenyi Biotec) and Vio Bright B515-conjugated EpCAM antibodies (130-111-007). The dilution was 1:50 for up to 106 cells in a final volume of 100 µL of blocking buffer. The dilution

(2) Expression of stem cell markers in the human fetal kidneyPloS oneAugust 21, 2009Metsuyanim S, Harari-Steinberg O, Buzhor E, Omer D, Pode-Shakked N, Ben-Hur H, Halperin R, Schneider D, Dekel B.

(3) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasisBreast cancer research : BCRJanuary 1, 2006Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.

(4) Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma markerBritish journal of cancerDecember 1, 1987Moldenhauer G, Momburg F, Möller P, Schwartz R, Hämmerling GJ.

Be the First to Write a Review!

Cancers

CD326 (EpCAM) Antibody, anti-human, Vio® Bright B515, REAfinity™ from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (4)

Reviews

CD326 (EpCAM) Antibody, anti-human, Vio® Bright B515, REAfinity™ from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map